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Abstract
Background: The cytokine tumor necrosis factor a (TNFa) is an established pain modulator in both the peripheral
and central nervous systems. Modulation of nociceptive synaptic transmission in the spinal cord dorsal horn (DH) is
thought to be involved in the development and maintenance of several pathological pain states. Increased levels
of TNFa and its receptors (TNFR) in dorsal root ganglion (DRG) cells and in the spinal cord DH have been shown
to play an essential role in neuropathic pain processing. In the present experiments the effect of TNFa incubation
on modulation of primary afferent synaptic activity was investigated in a model of peripheral neuropathy.
Methods: Spontaneous and miniature excitatory postsynaptic currents (sEPSC and mEPSCs) were recorded in
superficial DH neurons in acute spinal cord slices prepared from animals 5 days after sciatic nerve transection and
in controls.
Results: In slices after axotomy the sEPSC frequency was 2.8 ± 0.8 Hz, while neurons recorded from slices after
TNFa incubation had significantly higher sEPSC frequency (7.9 ± 2.2 Hz). The effect of TNFa treatment was smaller
in the slices from the control animals, where sEPSC frequency was 1.2 ± 0.2 Hz in slices without and 2.0 ± 0.5 Hz
with TNFa incubation. Tetrodotoxin (TTX) application in slices from axotomized animals and after TNFa incubation
decreased the mEPSC frequency to only 37.4 ± 6.9% of the sEPSC frequency. This decrease was significantly higher
than in the slices without the TNFa treatment (64.4 ± 6.4%). TTX application in the control slices reduced the
sEPSC frequency to about 80% in both TNFa untreated and treated slices. Application of low concentration TRPV1
receptors endogenous agonist N-oleoyldopamine (OLDA, 0.2 μM) in slices after axotomy induced a significant
increase in mEPSC frequency (175.9 ± 17.3%), similar to the group with TNFa pretreatment (158.1 ± 19.5%).
Conclusions: Our results indicate that TNFa may enhance spontaneous transmitter release from primary afferent
fibres in the spinal cord DH by modulation of TTX-sensitive sodium channels following sciatic nerve transection.
This nerve injury also leads to enhanced sensitivity of presynaptic TRPV1 receptors to endogenous agonist.
Modulation of presynaptic receptor activity on primary sensory terminals by TNFa may play an important role in
neuropathic pain development.
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Background
It is now well established that neuroinflammation can
facilitate or directly produce pain due to increased release
of different cytokines which in turn recruit immune cells
and activate glial cells [1,2], especially under neuropathic
conditions [3,4]. The cytokine tumor necrosis factor a
(TNFa) is now recognized as a pain modulator partici-
pating in both the peripheral and central processes lead-
ing to neuropathic pain following peripheral nerve injury
[5]. Several studies demonstrated increased TNFa levels
in DRG [6-8] and spinal cord [9-11] in different models
of peripheral neuropathy. The main sources of cytokines
in the spinal cord DH are activated glial cells [1,10-12].
Recently, it was shown that acute application or incuba-
tion of spinal cord slices with TNFa modulates excitatory
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the spinal cord DH. Furthermore, intrathecal application
of exogenous TNFa induced mechanical allodynia and
thermal hyperalgesia in rats and mice [13-15]. Pain
hypersensitivity associated with peripheral neuropathy
was attenuated by the TNFa antagonist etanercept
[19,20].
The effect of TNFa is mediated by two receptors, the
TNFR1 (p55) and the TNFR2 (p75). Both receptors were
detected in DRG and spinal cord neurons [21,22]. Up-
regulation of TNFR1/2 receptors in DRG neurons
[23-25] and TNFR1 in the spinal cord DH [11,26] was
demonstrated in different models of peripheral neuropa-
thy. Presumably, TNFR1 and TNFR2 differentially regu-
late nociceptive signaling. A crucial role of peripheral
TNFR1 receptors activation was demonstrated in the
CCI model of neuropathy [27]. In addition, using TNFR1
or TNFR2 knockout mice it was shown that development
of thermal hyperalgesia after CCI depended upon the
TNFR1 gene, whereas mechanical allodynia was present
in both TNFR1 or TNFR2 knockout mice [28]. The
importance of TNFR2 receptors in the excitation of pri-
mary sensory neurons after spinal nerve ligation (SNL)
was demonstrated using proteins that selectively activate
TNFR1 or TNFR2 receptors [29]. The same study indi-
cated a decrease in mechanical and thermal withdrawal
thresholds induced by intrathecal injection of a selective
TNFR1 but not TNFR2 agonist in control rats, whereas
coinjection of both selective agonists induced robust pain
hypersensitivity [29]. By using TNFR1 and TNFR2
knockout mice it was shown that thermal hyperalgesia
induced by intrathecal injection of TNFa could be
mediated by both TNFR1 or TNFR2 receptors, but it was
completely abolished in TNFR1/2 double knockout mice
[15]. TNFa application evoked an increase in the sponta-
neous EPSC frequency in the superficial DH neurons,
which was eliminated in the TNFR1 knockout mice and
reduced in the TNFR2 -/- mice [15].
Voltage activated sodium channels (Nav), especially the
tetrodotoxin-sensitive (TTX-S) Nav 1.3 and tetrodotoxin-
resistant (TTX-R) Nav 1.8 channels were implicated in
neuropathic pain states [30]. It was demonstrated that
following sciatic nerve axotomy, expression of Nav 1.3
channel mRNA was up-regulated, while Nav 1.8 mRNA
was down-regulated in small DRG neurons [31,32].
This corresponds well to the observed four times faster
recovery from inactivation of TTX-S sodium currents in
axotomized than control small DRG neurons and down-
regulation of TTX-R currents [33]. Nav 1.3 channels are
present in embryonic, but not in adult DRG neurons and
are re-expressed under pathological condition [31]. In
spinal nerve ligation (SNL) neuropathy, mechanical allody-
nia and thermal hyperalgesia were attenuated with reduc-
tion of TTX-R current in DRG neurons by specific
knockdown of Nav 1.8 with antisense oligodeoxynucleo-
tides [34]. Antisense oligodeoxynucleotides targeting Nav
1.8 also attenuated hypersensitivity in the chronic con-
striction injury (CCI) model [35]. In injured DRG neurons
Nav 1.8 protein expression decreased [36], but there was
an increase in Nav 1.8 immunoreactivity along the sciatic
nerve following SNL [37]. It was proposed that Nav 1.8
channels in uninjured DRG neurons contribute to the
hyperexcitability of these neurons, which may be critical
for the development of neuropathic pain [37]. These stu-
dies indicate that the expression of Nav channels and their
function in primary afferent neurons could be differentially
regulated in injured and in uninjured neurons, suggesting
that up-regulation of TTX-S Nav 1.3 channels is crucial in
injured neurons whereas increases of TTX-R Nav 1.8
channels are more important in uninjured DRG neurons
during neuropathy. Interestingly, TNFa may affect expres-
sion of both channels as peri-sciatic administration of
TNFa up-regulated Nav 1.3 and 1.8 in DRG neurons [38].
Transient receptor potential vanilloid 1 receptors
(TRPV1) are well recognized as molecular integrators of
nociceptive stimuli in the periphery. Recently, the presy-
naptic TRPV1 receptors on the central branches of pri-
mary afferent neurons in the spinal cord were shown to
have important roles in nociceptive synaptic signaling
especially under pathological conditions [39-41]. Coex-
pression of TNFR1 and TRPV1 receptor mRNA [42]
and colocalization of TNFR1 and TRPV1 immunoreac-
tivity [43] was reported in subsets of DRG neurons.
TNFa enhanced the sensitivity of cultured DRG neu-
rons to capsaicin application [44] and induced increased
expression of TRPV1 receptors on DRG [43] and tri-
geminal ganglion neurons [45]. This increased expres-
sion of TRPV1 receptors was TNFR1 dependent in
naïve mice [43] in contrast to tumor-bearing mice,
where up-regulation of TRPV1 receptors was dependent
on TNFR2 [46]. In our previous experiments we have
demonstrated increased sensitivity of presynaptic
TRPV1 receptors to the endogenous vanilloid agonist
N-oleoyldopamine (OLDA) after TNFa treatment in
spinal cord slices from control animals [16]. The
absence of DRG in our preparation indicated that this
effect was due to phosphorylation of native TRPV1
receptors as opposed to their increased expression [47].
It was shown that capsaicin-evoked current was robustly
potentiated via activation of PKC or p38/MAP kinase
after TNFa application in cultured DRG neurons [46].
In the present study, we have examined the modula-
tion of synaptic transmission by TNFa in the superficial
spinal cord DH after sciatic nerve transection and in
control animals. The effect of acute slice incubation
with TNFa on the spontaneous and miniature EPSCs
and on TRPV1 receptor activation by the endogenous
agonist OLDA was investigated.
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All experiments were approved by the local Institutional
Animal Care and Use Committee and were consistent
with the guidelines of the International Association for the
Study of Pain, the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and the European
Communities Council Directive of 24 November 1986 (86/
609/EEC).
Sciatic nerve transection
Male Wistar rats on postnatal day P18 to P22 were
anesthetized with ether. For axotomy both sciatic nerves
were exposed at midthigh level and transected using
sharp scissors. The wound was closed and animals were
left to recover in their home cages.
Spinal cord slices preparation
A c u t es p i n a lc o r ds l i c e sw e r ep r e p a r e df r o mm a l eW i s t a r
rats P20 - P27, as was previously described [39]. After
anesthesia with ketamine (150 mg/kg, i.p.) and xylazine
(16 mg/kg, i.p.), the lumbar spinal cord was removed and
immersed in oxygenated ice-cold dissection solution con-
taining (in mM): 95 NaCl, 1.8 KCl, 7 MgSO4,0 . 5C a C l 2,1 . 2
KH2PO4,2 6N a H C O 3, 25 D-glucose, 50 sucrose. The spinal
cord was fixed to a vibratome stage (Leica, VT 1000 S,
Germany) in a groove between two agar blocks using cya-
noacrylate glue. Acute transverse slices 300 μm thick were
cut from lumbar segments L3-L5, incubated in the dissec-
tion solution for 30 min at 33°C and then stored in a
recording solution at room temperature and allowed to
recover for 1 h before the electrophysiological experiments.
Recording solution contained (in mM): 127 NaCl, 1.8 KCl,
1.2 KH2PO4, 2.4 CaCl2, 1.3 MgSO4,2 6N a H C O 3, 25 D-glu-
cose. In some experiments the slices were incubated for at
least 2 h with TNFa (60 nM added in the bath). Electro-
physiological measurements were made from slices trans-
ferred into a recording chamber that was perfused
continuously with recording solution at a rate ~2 ml/min.
All extracellular solutions were saturated with carbogen
(95% O2,5 %C O 2) during the whole process.
Electrophysiological recordings
Patch-clamp recordings were made from individual DH
neurons visualized using a differential interference con-
trast (DIC) microscope (Leica, DM LFSA, Germany)
equipped with an infrared-sensitive camera (IR camera
Hitachi KP-200 P, Japan) with a standard TV/video
monitor (Hitachi VM-172, Japan). Patch pipettes were
pulled from borosilicate glass tubing (Rückl Glass, Otvo-
vice, Czech Republic) with resistances of 3.5 - 6.0 MΩ
when filled with intracellular solution. The intracellular
pipette solution contained (in mM): 125 gluconic acid
lactone, 15 CsCl, 10 EGTA, 10 HEPES, 1 CaCl2,
2N a 2ATP, 0.5 NaGTP and was adjusted to pH 7.2 with
CsOH. Voltage-clamp recordings in the whole-cell con-
figuration were performed with an Axopatch 200 B
amplifier and 1440 A digitizer (Molecular Devices, USA)
at room temperature (~23°C). Whole-cell responses
were low-pass filtered at 2 kHz and digitally sampled at
10 kHz. The series resistance of neurons was routinely
compensated by 80% and was monitored during the
whole experiment. AMPA receptor-mediated sponta-
neous or miniature EPSCs were recorded from superfi-
cial DH neurons in laminae I and II, clamped at -70 mV
in the presence of 10 μMb i c u c u l l i n ea n d5μMs t r y c h -
nine. Miniature EPSCs were distinguished by addition of
0.5 μM tetrodotoxin (TTX) to the recording solution.
Lidocaine (1 mM) was added in other experiments to
block TTX-R sodium channels. The software package
pCLAMP version 10 (Molecular Devices, USA) was
used for data acquisition and subsequent off-line analy-
sis. Neurons with capsaicin-sensitive primary afferent
input were identified by an increase of EPSC frequency
(> 20%) following capsaicin (0.2 μM) administration at
the end of the experimental protocol.
Drug treatment
All drugs used in this study were of analytical grade and
purchased from Sigma-Aldrich (Prague, Czech Republic)
or Tocris Bioscience (Bristol, UK). TNFa was dissolved in
0.1% BSA; capsaicin and OLDA were dissolved in
dimethylsulfoxide (DMSO), which had a concentration <
0.1% in the final solution.
Data analysis
Data segments of 2 min duration were analyzed for each
experimental condition. Only EPSCs with an amplitude of
5 pA or greater (which corresponded to at least twice the
recording noise level) were included in the frequency ana-
lysis. In the case of amplitude analysis, the same events
and data segments were used. Data are expressed as
means ± standard error of the mean (SEM). Some data
were normalized as a percentage of the control values
(100%). Paired t-test, one-way ANOVA or one-way
ANOVA repeated measures followed by post hoc test
(Bonferroni) were used for statistical comparisons and P <
0.05 was considered to be statistically significant.
Results
Five days after the sciatic nerve transection spontaneous
and miniature AMPA EPSCs were recorded in spinal cord
slices without and after incubation with TNFa (60 nM).
The absolute sEPSC frequency in the DH neurons after
axotomy was 2.83 ± 0.83 Hz and decreased to 1.52 ± 0.34
Hz (n = 18, P < 0.001) after TTX application (Figure 1A,
C). In slices from control animals TTX application
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TNFa treatment. C) TNFa (60 nM) pretreatment robustly increased the frequency of sEPSC in slices after sciatic nerve section (n = 12,
##P<
0.01) compared to non-pretreated slices (n = 18). Mean mEPSC frequency was similar after acute tetrodotoxin (TTX, 0.5 μM) application in both
groups, with and without TNFa treatment and significantly reduced compared to the sEPSC frequency (***P < 0.001). D) Mean sEPSC (n = 9,
##P < 0.01) and mEPSC (
#P < 0.05) frequency was significantly higher in control animals after TNFa treatment. TTX application reduced sEPSC
frequency significantly in both TNFa treated (*P < 0.05) and non-treated slices (**P < 0.01). E) TTX application dramatically decreased sEPSC
frequency in spinal cord slices after axotomy pretreated with TNFa (n = 12). This TNFa induced TTX dependent decrease of sEPSC frequency
was not present in control slices (n = 9). TTX induced decrease of sEPSC frequency in slices after axotomy without TNFa treatment (n = 18) was
not statistically different from the results in the control group (n = 20). *: comparison of mEPSC versus sEPSC; #: comparison of TNFa treated
sEPSC and mEPSC versus non-treated sEPSC and mEPSC, respectively. F) Lidocaine application reduced mEPSC frequency present during TTX
application in neurons from control (n = 6) and axotomized (n = 7) slices. Effect of lidocaine application was not significant after TNFa
treatment in the neurons recorded in the control (n = 8) and axotomized (n = 8) slices.
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0.17 Hz (n = 20, P < 0.01, Figure 1B, D). Spontaneous and
mEPSC frequency in DH neurons in slices after axotomy
was higher than in control animals, but this difference was
not statistically significant. In slices after axotomy incu-
bated with TNFa, the absolute sEPSC frequency was 7.89
± 2.21 Hz and decreased to 1.83 ± 0.40 Hz (n = 12, P <
0.001) after TTX application (Figure 1A, C). Spontaneous
EPSC frequency in TNFa incubated slices in control ani-
mals decreased due to TTX application from 2.03 ± 0.53
Hz to 1.45 ± 0.25 Hz (n = 9, P < 0.05, Figure 1B, D).
There was evident TNFa mediated increase of the sEPSC
frequency in slices after sciatic nerve transection when
compared to control slices (P < 0.05), while the low differ-
ence between mEPSC in these two groups was not signifi-
cant (Figure 1C, D). These results indicate that TNFa
increases sEPSC frequency in axotomized DH neurons via
enhanced activity at TTX-S Nav channels. This is even
more evident after standardization of the results. Under
this evaluation, tetrodotoxin application reduced the fre-
quency of spontaneous EPSC to 64.4 ± 6.4% (n = 18, P <
0.001) in neurons after axotomy without TNFa treatment,
but these were decreased to only 37.4 ± 6.9% (n = 12, P <
0.001) with TTX application in spinal cord slices pre-
treated with TNFa (Figure 1E). This robust TTX induced
decrease of EPSC frequency in TNFa pretreated slices was
statistically different from the TTX effect in non-pre-
treated slices in the axotomy group (P < 0.01) and from
the TTX effect in control animals (P < 0.001). There was
no difference between the TTX induced reductions of
EPSC frequency in neurons incubated with TNFa (80.9 ±
6.6, n = 9, P < 0.05) and non-pretreated slices (77.8 ± 6.4,
n = 20, P < 0.01) in control animals.
The mean amplitude of the sEPSC was 29.7 ± 2.5 pA in
the neurons after axotomy and decreased to 25.2 ± 2.0
pA (mEPSC) after TTX application (n = 18, P < 0.001,
Figure 2A). In the group of TNFa pretreated neurons
after axotomy the results were similar, with mean sEPSC
amplitude of 35.2 ± 4.7 pA and mEPSC amplitude 28.6 ±
3.0 pA (n = 12, P < 0.01). In control animals, the mean
sEPSC amplitude (29.7 ± 2.2 pA) decreased after TTX
application to 25.9 ± 1.4 pA (n = 20, P < 0.05). Control
TNFa pretreated neurons had sEPSC amplitude of 22.6 ±
1.9 pA and mEPSC of 21.1 ± 1.8 pA (n = 9). Neither
sEPSC or mEPSC amplitudes were statistically different
between the DH neurons in TNFa pretreated slices and
non-treated slices from both injured and control animals.
The standardized mean sEPSC amplitudes (100%) were
higher than the mEPSC amplitudes in both axotomized
and control slices, with and without TNFa treatment
(Figure 2B). There was no difference in the TTX induced
reduction of the mean sEPSC amplitude between the
TNFa treated (85.1 ± 4.2%, n = 12, P < 0.01) and non-
treated group (86.2 ± 2.6%, n = 18, P < 0.001) after
axotomy (Figure 2B). In slices from the control rats, the
TTX induced reduction of the mean sEPSC amplitude
was only small, 94.7 ± 4.2% (n = 9) in the TNFa pre-
treated group and 91.1 ± 3.3% (n = 20, P < 0.05) in the
slices without TNFa treatment.
To assess the role of TTX-R Nav channels, lidocaine (1
mM) was used together with TTX in some experiments.
In slices from axotomized animals the mEPSC frequency
decreased after lidocaine application to 70.1 ± 6.6% (n =
7, P < 0.01), when mEPSC frequency during the TTX
application was considered 100% (Figure 1F). In axoto-
mized slices with TNFa treatment, lidocaine application
did not induce significant change in mEPSC frequency
(93.3 ± 6.0%, n = 8) from the TTX level, but was signifi-
cantly different from the TNFa untreated slices (P <
0.05). In DH neurons from control animals the mEPSC
frequency decreased after lidocaine application to 76.5 ±
11.4% (n = 6, P < 0.05). The decrease of mEPSC fre-
quency after lidocaine application in TNFa treated con-
trol slices (86.3 ± 4.9%, n = 8) was not statistically
different from the frequency during the TTX application
or from recordings in the control slices without TNFa
treatment.
The mean amplitude of the mEPSCs recorded in the
presence of lidocaine was not different from mEPSC
amplitude recorded in the presence of TTX only (axot-
omy: 104.8 ± 3.5%, axotomy with TNFa:1 0 3 . 1±7 . 3 % ,
CTRL: 97.7 ± 2.9%, CTRL with TNFa: 91.3 ± 3.3%).
Next, TNFa modulation of spinal TRPV1 receptors acti-
vation by endogenous agonist OLDA after sciatic nerve
transection was investigated. We have previously demon-
strated that application of a low concentration OLDA
(0.2 μM) does not evoke any changes in the mEPSC fre-
quency in control slices [16,39]. This was also confirmed
in the present experiments, where application of 0.2 μM
OLDA solution did not change the mEPSC frequency
(94.8 ± 5.0%, n = 6) in slices from control animals. How-
ever, the application of low concentration OLDA solution
(0.2 μM) increased the mEPSC frequency to 175.9 ± 17.3%
(n = 13, P < 0.01) when compared to the control values
before the OLDA application, in acute spinal cord slices
prepared from animals 5 days after the sciatic nerve trans-
ection (Figure 3A). Final capsaicin application (0.2 μM)
increased the mEPSC frequency substantially (699.2 ±
426.9%), in this group of DH neurons. OLDA application
in the neurons recorded in slices after axotomy and with
the TNFa pretreatment increased the mEPSC frequency
158.1 ± 19.5% (n = 14, P < 0.05) and the capsaicin applica-
tion increased mEPSC frequency to 860.2 ± 343.2%.
OLDA induced increase of the mEPSC frequency was not
statistically different between the TNFa pretreated and
non-treated slices from the axotomized animals. The
mEPSC frequency (in Hz) recorded in the TNFa incu-
bated slices prepared from the animals after axotomy was
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= 14) when compared to the mEPSC frequency recorded
in slices without TNFa treatment (mEPSC: 0.97 ± 0.22
Hz, OLDA: 1.51 ± 0.30 Hz, n = 13, Figure 3B), but this dif-
ference was not statistically significant. All of the tested
neurons responded to capsaicin application. OLDA appli-
cation did not change the mean mEPSC amplitude in the
recorded superficial DH neurons without (mEPSC: 23.7 ±
2.5 pA, OLDA: 23.6 ± 2.6 pA, n = 13) and with TNFa pre-
treatment (mEPSC: 28.0 ± 2.9 pA, OLDA: 25.9 ± 2.7 pA, n
= 14) following peripheral nerve injury, similar to our
results demonstrated in control animals [39].
Discussion
There is now mounting evidence of TNFa importance
in the processing of nociceptive information at the
spinal cord level following peripheral nerve injury. In
our study we have examined the possible role of TNFa
in modulation of synaptic transmission at superficial DH
neurons in a model of peripheral neuropathy. Our
Figure 2 A) The mean amplitude of sEPSC and mEPSC was not different in the axotomy groups of neurons with and without TNFa
treatment. Tetrodotoxin application (0.5 μM) decreased sEPSC amplitude in both TNFa treated (n = 12, **P < 0.01) and non-treated (n = 18,
***P < 0.001) superficial dorsal horn neurons after axotomy. B) The reduction of sEPSC amplitude after TTX application was similar in both TNFa
treated (**P < 0.01) and non-treated (**P < 0.001) neurons.
Figure 3 A) Neurons recorded in slices after axotomy showed increased mEPSC frequency after endogenous TRPV1 agonist N-
oleoyldopamine application (OLDA, 0.2 μM, n = 13, **P < 0.01). The OLDA induced mEPSC frequency increase was similar in TNFa treated
slices (n = 14, **P < 0.05). B) The absolute mEPSC frequency recorded in the neurons after TNFa treatment was higher compared to the non-
treated group, but this difference did not reach statistical significance.
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presynaptic TTX-S sodium channels activity, 5 days
after sciatic nerve axotomy. The nerve injury also
increased sensitivity of presynaptic TRPV1 receptors to
endogenous agonist OLDA. These changes in function
of presynaptic primary afferent ending in our experi-
ments were most likely related to nociception in vivo,a s
the neurons recorded were in the superficial DH lami-
nae and most of them received capsaicin sensitive input.
TNFa in our experiments induced robust increases of
sEPSC frequency in the DH neurons recorded after the
sciatic nerve transection, while in control animals the
effect of TNFa incubation was only moderate. This
TNFa induced sEPSC frequency increase after nerve
injury was most likely mediated by increased expression
of TNFR1 receptors and activation of TTX-S Nav chan-
nels, as TTX application reduced the sEPSC frequency
to only 37% of the original level. The cytokines were
shown to have significant impact on sodium channels
activity in vitro and in different models of neuropathic
pain. In cultured DRG neurons TNFa enhanced TTX-R
sodium currents via activation of TNFR1 receptors and
p38 MAPK [48]. Model of neuropathy induced by L5
ventral root transection (L5-VRT) accompanied with
mechanical allodynia and thermal hyperalgesia increased
immunoreactivity for TNFa and TNFR1 receptors in
the ipsilateral DRG and bilaterally in the spinal cord DH
[26]. Inhibition of TNFa synthesis in this model, pre-
vented p38 MAPK activation in DRG neurons and
spinal cord microglia, which was necessary for the initia-
tion and maintenance of neuropathic pain [49]. The L5-
VRT also increased Nav 1.3 and Nav 1.8 mRNA, protein
level and current densities of TTX-S and TTX-R
sodium channels in DRG neurons [38]. Interestingly,
both Nav 1.3 and Nav 1.8 up-regulation was mediated
by cytokine TNFa, as was shown by inhibition of TNFa
synthesis [26,38]. The increase of sodium currents in
DRG neurons evoked by L5-VRT was not present in
TNRF1 knockout mice [50]. Our results in the periph-
eral nerve axotomy model suggest increased glutamate
release from the presynaptic primary afferent endings in
the spinal cord due to TTX-S Nav channels activity.
The DRG cell bodies were absent during the incubation
of spinal cord slices with TNFa. Therefore the increased
spontaneous activity was most likely mediated through
modulation of TTX-S Nav channels function, such as
their phosphorylation/dephosphorylation [51], trafficking
from the cytoplasm to the presynaptic membrane [52]
or possibly also by their local synthesis in the presynap-
tic ending. Recently ERK1/2 mitogen-activated protein
kinase phosphorylation of TTX-S Nav 1.7 channels was
shown to regulate gating properties of the channel and
resting membrane properties of DRG neurons [53]. The
Nav 1.3 channels up-regulated following axotomy
display rapid activation and inactivation [31,33]. It was
s u g g e s t e dt h a tt h ei n c r e a s e dr e c o v e r yr a t e sf r o mi n a c t i -
vation of Nav 1.3 channels expressed along the axon
after axotomy compared to Nav 1.7 channels present
under control conditions in small DRG neurons, could
contribute to increased excitability of DRG neurons
under neuropathic pain conditions [30]. Presynaptic Nav
channels modulate the presynaptic action potential, sub-
sequent Ca
2+ influx and thus transmitter release.
Increased expression of TTX-S channels at the presy-
naptic ending could thus lead to amplification of the
presynaptic potential and increased Ca
2+ influx and glu-
tamate release [54]. Our results support the hypothesis
that presynaptic TTX-S Nav channels on spinal cord
primary afferent endings could mediate increased trans-
mitter release and thus contribute to neuropathic pain
hypersensitivity.
Our results with lidocaine application showed involve-
ment of presynaptic TTX-R Nav channels in regulation
of mEPSC frequency recorded in superficial dorsal horn
neurons. There was no significant difference between the
control and axotomized animals. Minimal effect of lido-
caine application on the mEPSC frequency in neurons
from axotomized slices after TNFa incubation suggested
reduced participation of TTX-R Nav channels under
these conditions. Downregulation of Nav 1.8 channel
mRNA expression [32] and TTX-R sodium currents [33]
has been shown in DRG neurons following sciatic nerve
axotomy. In our preparation TTX-R Nav channel invol-
vement in regulation of mEPSCs frequency was signifi-
cantly reduced after the TNFa treatment, suggesting
important regulatory role of this cytokine. In contrast, Jin
and Gereau (2006) demonstrated enhancement of TTX-
R sodium currents in cultured DRG neurons after acute
TNFa application. This discrepancy is most likely due to
different experimental conditions between the DRG cul-
tures and the spinal cord slices with only central branch
of the primary afferent present, different duration of the
TNFa application and altered regulation of TTX-R Nav
channels in injured and uninjured DRG neurons by
TNFa [38,50].
In our experiments there was only a small reduction of
the mean sEPSC amplitude after TTX application, irre-
spective of the TNFa treatment (control slices ~93%,
axotomy ~86%). This would suggest that there was very
low proportion of sEPSC present due to propagation of
action potentials in the superficial DH neurons in our
spinal slice preparation with cut dorsal roots before the
TTX treatment, in contrast to preparations with intact
neuronal circuits as in hippocampal slice preparation
[55]. The TNFa treatment did not induce any significant
change in sEPSC or mEPSC mean amplitude in the
recorded neurons, similar to our previous results in con-
trol animals [16] and in agreement with previous finding
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Page 7 of 9[13,15,56]. However, enhancement of AMPA mediated
postsynaptic currents by TNFa was shown in hippocam-
pal neurons due to increased expression of surface
AMPA receptor [57]. In the spinal cord, TNFa depen-
dent AMPA receptor trafficking was demonstrated in
association with peripheral inflammation [58] and cell
death following spinal cord injury [59]. Potentiation of
AMPA induced currents by TNFa was reported also in
the spinal cord DH neurons in control slices [13], while
two other studies did not find any TNFa modulation of
AMPA induced currents in DH neurons [15,56].
Our previous experiments on superficialD Hn e u r o n s
done under the same experimental conditions showed
that application of 10 μM OLDA solution was needed
to increase mEPSC frequency due to specific TRPV1
receptor activation, while lower OLDA concentrations
did not have an effect [39]. The OLDA concentration
needed to activate presynaptic TRPV1 receptors
decreased dramatically to 0.2 μM after PKC activation
by phorbol esters and in a model of peripheral inflam-
mation [39]. Results in this paper demonstrate increased
sensitivity of spinal presynaptic TRPV1 receptors to
endogenous agonist OLDA following sciatic nerve trans-
ection. We suggest that this responsiveness to low con-
centration (0.2 μM) OLDA solution could be mediated
by phosphorylation or up-regulation of presynaptic
TRPV1 receptors [60]. One of the mechanisms involved
could be also increased expression of TNFR1 receptors
in the DRG neurons following the nerve lesion [11]. In
the experiments described in this paper, the increase of
mEPSC frequency after the OLDA application was com-
parable in the neurons recorded after axotomy irrespec-
tive of the TNFa treatment. This is in contrast to our
previous results in control slices, where TNFa treatment
induced response to low concentration (0.2 μM) OLDA,
not present in controls [16]. The lack of TNFa incuba-
tion effect in slices after axotomy may be due to already
sensitized TRPV1 receptors present at the presynaptic
endings. Decreased expression of TRPV1 receptors after
axotomy could also play a role [61].
Conclusions
Our results support an important regulatory role of the
proinflammatory cytokine TNFa in nociceptive proces-
sing at the spinal cord DH following sciatic nerve sec-
tion. We have demonstrated modulation of presynaptic
TTX sensitive sodium channel activity and increased
transmitter release by TNFa together with increased
sensitivity of presynaptic TRPV1 receptors to endogen-
ous agonist. These mechanisms could significantly affect
synaptic transmission in the spinal cord DH after nerve
injury and contribute to neuropathic pain development
or maintenance.
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